Our Life Sciences and Product Regulation and Consumer Protection teams have released two comprehensive mid-year reviews. The publications offer timely insights into the evolving regulatory landscape for digital health and consumer products in the EU.
The
Digital Health Review examines key developments shaping the sector in 2024. It
compares EU and UK approaches to medical device regulation, providing valuable
information for cross-market operators. The guide also outlines the AI Act's
compliance timeline for medical devices and explores proposed changes to EU
product liability rules.
Read the Digital Health Review
Complementing this, the Products & Consumer Protection Review focuses on shifts in EU consumer safeguards. It analyses the potential impact of revised product liability directives on AI-enabled products. The review also delves into liability issues surrounding AI chatbot 'hallucinations' and examines the EU Data Act's implications for connected devices.
Both publications address the intersection of AI and regulatory frameworks. They offer practical insights for businesses navigating the complex interplay of technology and legislation.
Read the Products & Consumer Protection Review
If you have a question about any of the topics discussed, don't hesitate to contact a member of our Life Sciences team.
